Clinical studies on tosufloxacin (TFLX) in urology

We clinically evaluated the usefulness of a new oral antimicrobial agent, TFLX, in the field of urology. The dose administered was 150 mg t.i.d and the duration of administration was 3 days. The clinical effect was evaluated according to the criteria of the Japanese UTI committee. The clinical respo...

Description complète

Détails bibliographiques

Publié dans:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 38(1992), 4 vom: 27. Apr., Seite 501-6
Auteur principal:	Fukushima, S (Auteur)
Autres auteurs:	Moriyama, M, Miyamoto, H, Hosaka, M, Kubota, Y, Kinoshita, Y, Noguchi, K, Shuin, T, Noguchi, S, Yoshimura, S
Format:	Article
Langue:	Japanese
Publié:	1992
Accès à la collection:	Hinyokika kiyo. Acta urologica Japonica
Sujets:	Clinical Trial English Abstract Journal Article Multicenter Study 4-Quinolones Anti-Infective Agents Fluoroquinolones Naphthyridines tosufloxacin GHJ553KQPS